Live Breaking News & Updates on Domain Associates

Stay updated with breaking news from Domain associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Singular Genomics is latest early stage San Diego startup to seek an IPO


Print
Singular Genomics, a San Diego startup that’s developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company.
Founded in 2016, Singular hasn’t disclosed yet how much money it hopes to raise or the proposed price range of its shares. That information should be revealed as Singular gets closer to pricing its initial public stock offering.
But it is attempting an IPO at a time when investors are receptive to betting on early stage companies. There have been 141 IPOs priced globally so far this year, up more than 300 percent from the same period last year, according to Renaissance Capital, an IPO investment advisory firm. San Diego-based TuSimple, which is developing self-driving semi-truck technology, recently raised $1 billion in an IPO. ....

San Diego , United States , Eli Glezer , Andrew Spaventa , Pacific Biosciences , Nasdaq Exchange , Goldman Sachs , Thermo Fisher , Domain Associates , Singular Genomics , Renaissance Capital , Diego Based Tusimple , Deerfield Management , Legend Capital , March Venture , Bofa Securities , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பெஸிஃபிக் உயிர் அறிவியல் , நாஸ்டாக் பரிமாற்றம் , கோல்ட்மேன் சாக்ஸ் , தெர்மோ மீனவர் , களம் கூட்டாளிகள் , ஒருமை மரபியல் , மறுமலர்ச்சி மூலதனம் , தீர்ப்பியல்ட் மேலாண்மை ,

Singular Genomics Files For IPO - socaltech.com


socaltech.com
La Jolla-based
Singular Genomics Systems, a developer of gene sequencing technology, has filed for an IPO, saying in a filing that it is looking to raise up to $100M in an IPO on the Nasdaq. The company has filed to list under the symbol OMIC. The IPO is being underwritten by J.P. Morgan, Goldman Sachs & Co. LLC, BofA Securities, Cowen, and UBS Investment Bank. The company s largest shareholders are Deerfield Management, Domain Associates, Legend Capital, and Arch Venture Partners. ....

Goldman Sachs Co , Domain Associates , Investment Bank , Jolla Based Singular Genomics Systems , Goldman Sachs , Bofa Securities , Deerfield Management , Legend Capital , March Venture , கோல்ட்மேன் சாக்ஸ் இணை , களம் கூட்டாளிகள் , முதலீடு வங்கி , கோல்ட்மேன் சாக்ஸ் , போஃபா பத்திரங்கள் , தீர்ப்பியல்ட் மேலாண்மை , புராண மூலதனம் , வளைவு துணிகர ,

Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript


Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Aldeyra Therapeutics (NASDAQ: ALDX)
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics first-quarter 2021 financial results conference call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. I would now like to hand the conference over to the company s chief financial officer, Joshua Reed.
Please go ahead, sir.
Chief Financial Officer
Good morning, everyone. With me is Dr. Todd Brady, president, and chief executive officer of Aldeyra. This morning we issued a press release reporting our financial results for the quarter ended March 31, 2021. ....

United States , Yale Jen , Esther Hong , Todd Brady , Esther Hong Berenberg , Parkhar Agrawal , Edwin Zhang , Kelly Shi Jefferies , Marc Goodman , Prakhar Agrawal Jonestrading , Justin Kim , Joshua Reed , Yigal Nochomovitz , Kelly Shi , Justin Kim Oppenheimer Company Analyst , Domain Associates , Yale Jen Laidlaw Company Analyst , Aldeyra Therapeutics , Motley Fool Aldeyra Therapeutics , Call Transcript , Motley Fool Logo , Motley Fool Stock Advisor , Stock Advisor , Foolish Best , Motley Fool , Obligatory Capitalized Disclaimers ,